FDA Inspection 1226812 — CMAX Clinical Research Pty Ltd
The FDA completed an inspection of CMAX Clinical Research Pty Ltd on November 10, 2023 in Adelaide. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 10, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Adelaide (Australia)
Additional Details
Clinical BA/BE